BioSpace News Archive

OPEN MINDS has announced that The Non-Profit Mergers, Acquisitions, & Affiliations Summit: Collaborations For Sustainability In The Next Normal will be held on March 9, 2021 prior to the annual OPEN MINDS Technology & Analytics Institute which will be held on March 10 and 11, 2021.

The pandemic has had a marked impact on the demand for social services — and the social determinants of health are directly related to rates of infection and mortality rates for COVID-19. On Tues

Adaptas Solutions, LLC, a leading manufacturer of critical components for mass spectrometers, analytical lab equipment and clinical instruments, has completed the acquisition of Cadence

- Tumor reductions observed in 6 of 7 patients treated at 300 mg BID following median 4 prior lines of therapy - - Patients receiving 300 mg BID have remained on therapy for extended periods of time (1 to 2 years) - - Two potential biomarkers identified that demonstrate target engagement and highlight potential for patient enrichment strategy - - Recommended Phase 2 dose of 300 mg BID balances durable anti-cancer activity and extended tolerability profile -

-- Pomalyst®, Kyprolis® and Revlimid® Arms of the Phase 1b/2 STOMP Study Evaluating Once Weekly XPOVIO with Low-Dose Dexamethasone Combinations Continue to Demonstrate Favorable Response Rates and Durability in Patients with Previously Treated Multiple Myeloma -- -- Multiple Subgroup Analyses from the Phase 3 BOSTON Study Demonstrate that XPOVIO Is Effective and Well Tolerated Regardless of Prior Lines of Treatment and Across Several Important Patient Subgroups

SOLVD Health (www.solvdhealth.com), a privately held company focused on preventing disease by making actionable and contextual health information accessible to everyone, announced today that its genetic risk assessment for opioid use disorder (OUD) has received CE mark certification.

Dr. Isaacs, co-CEO of The Permanente Federation, Recognized for Demonstrating Leadership and Impact in Influencing the Health Care Industry

Capital raised in 2020 increases by over 20% YoY. Investments in Israeli companies more than tripled in six years Israel records a sharp rise in high-tech investments compared with Europe, Asia, and America. Hundreds of Israeli technological innovation solutions implemented worldwide during COVID-19

With responsibility for the financial health and well-being of the organization, Mr. Dalgleish will oversee multiple departments, including Revenue Cycle Management, Accounting, and Financial Planning and Analysis.

With Tens of Millions of Americans Anticipated to Travel for the Holidays, Wellness 4 Humanity Aims to Provide Protection and Peace of Mind through Fast, Highly Accurate At-Home Testing